Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 ...

The prolific Medusa ransomware group claims to have stolen troves of data from HCRG, including patients’ sensitive health ...

Britain's blue-chip FTSE 100 kicked off the week higher on Monday, boosted by heavyweight healthcare and defence stocks, on ...

But it’s also fueling a two-track system, where patients with more easily treatable conditions can be seen relatively quickly ...

Britain will investigate the long-term effects of vaping on children as young as eight in a decade-long study of their health ...

Because of Prof MacMahon, who as a medical student dabbled as a hobbyist programmer, the Mater is now among the first ...

A report by the UK's independent public spending watchdog warned that only one of the government's five key targets for ...

The fourth grader was referred to a specialist in Lexington, who discovered he was a good candidate for a new type of ...

DuJuan Broadus strolled into the conference room inside the Kentucky Clinic. When greeted, he heard me with no trouble at all ...

As the global healthcare landscape grows more complex, the demand for skilled leaders who can innovate, collaborate and ...

UHL and UHN Group have used AI to become the first NHS organisation in England to join the European Trustworthy and ...

"The MHRA's authorization of our RSV vaccine is an important milestone for Moderna's efforts toward respiratory disease preparedness," said Stéphane Bancel, Chief Executive Officer of Moderna. "Our ...